NILVAD protocol: a European multicentre double-blind placebo-controlled trial of nilvadipine in mild-to-moderate Alzheimer's disease

INTRODUCTION: This study is a European multicentre, randomised, double-blind, placebo-controlled trial investigating the efficacy and safety of nilvadipine as a disease course modifying treatment for mild-to-moderate Alzheimer's disease (AD) in a phase III study that will run for a period of 82...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Lawlor, Brian, Kennelly, Sean, O'Dwyer, Sarah, Cregg, Fiona, Walsh, Cathal, Coen, Robert, Kenny, Rose Anne, Howard, Robert, Murphy, Caroline, Adams, Jessica, Daly, Leslie, Segurado, Ricardo, Gaynor, Siobhan, Crawford, Fiona, Mullan, Michael, Lucca, Ugo, Banzi, Rita, Pasquier, Florence, Breuilh, Laetitia, Riepe, Matthias, Kalman, Janos, Wallin, Anders, Borjesson, Anne, Molloy, William, Tsolaki, Magda, Olde Rikkert, Marcel
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2014
Assuntos:
Geriatric Medicine
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4194801/
https://ncbi.nlm.nih.gov/pubmed/25300460
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2014-006364
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados